Breast and Ovarian Cancer Genomics

51 – 60 of 94

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001128?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
5
6
7
8
…
10
next »

2021
Mark Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, Laura ^LU ; Li, Minerva ^LU ; Veerla, Srinivas ^LU and Hedenfalk, Ingrid ^LU (2021)
- Contribution to conference › Poster
Mark Homologous recombination repair mechanisms in serous endometrial cancer
Jönsson, Jenny Maria ^LU ; Bååth, Maria ^LU ; Björnheden, Ida ; Sahin, Irem Durmaz ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2021) In Cancers 13(2).
- Contribution to journal › Article
Mark Common Susceptibility Loci for Male Breast Cancer
Maguire, Sarah ; Olsson, Håkan ^LU ; Hedenfalk, Ingrid ^LU and Orr, Nick (2021) In Journal of the National Cancer Institute 113(4). p.453-461
- Contribution to journal › Article
Mark MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, Maria ^LU ; Jönsson, Jenny-Maria ^LU ; Westbom Fremer, Sofia ^LU ; Martin de la Fuente, Laura ^LU ; Tran, Lena ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU ; Honeth, Gabriella ^LU and Hedenfalk, Ingrid ^LU (2021) In Genes 12(5).
- Contribution to journal › Article
Mark Cancer stem cells and homologous recombination deficiency in serous ovarian and endometrial carcinoma
Bååth, Maria ^LU (2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
Mark Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila ^LU ; Akrap, Nina ^LU ; Staaf, Johan ^LU ; Alves, Carla L ; Ehinger, Anna ^LU ; Ebbesson, Anna ^LU ; Hedenfalk, Ingrid ^LU ; Beumers, Lukas ^LU ; Veerla, Srinivas ^LU and Harbst, Katja ^LU , et al. (2021) In Breast cancer research : BCR 23(1). p.26-26
- Contribution to journal › Article
Mark A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated with Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor) : A Report of 22 Cases
Bennett, Jennifer A. ; Young, Robert H. ; Howitt, Brooke E. ; Croce, Sabrina ; Wanjari, Pankhuri ; Zhen, Chaojie ; Da Cruz Paula, Arnaud ; Meserve, Emily ; Schoolmeester, J. Kenneth and Westbom-Fremer, Sofia ^LU , et al. (2021) In American Journal of Surgical Pathology 45(8). p.1061-1074
- Contribution to journal › Article
Mark Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
Matikas, A. ; Wang, K. ^LU ; Lagoudaki, E. ; Acs, B. ; Zerdes, I. ; Hartman, J. ; Azavedo, E. ; Bjöhle, J. ; Carlsson, L. and Einbeigi, Z. , et al. (2021) In ESMO Open 6(2).
- Contribution to journal › Article
2020
Mark PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura ^LU ; Westbom-Fremer, Sofia ^LU ; Arildsen, Nicolai Skovbjerg ^LU ; Hartman, Linda ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2020) In Virchows Archiv: an international journal of pathology 477(1). p.83-91
- Contribution to journal › Article
Mark Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
Arildsen, Nicolai Skovbjerg ^LU and Hedenfalk, Ingrid ^LU (2020) In Oncotarget 11(40). p.3660-3674
- Contribution to journal › Article

« previous
1
…
5
6
7
8
…
10
next »